Pascal Biosciences Inc (PAS)
TSXV
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current PAS market cap is 572.1k. The company's latest EPS is CAD -0.0105 and P/E is -0.95.
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 6k | 672k |
| Operating Income | -2.84M | -983k | -786k | -291k | -622k |
| Net Income | -3.41M | -1.24M | -1.09M | -480k | -400k |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 455k | 121k | 155k | 18k | 2.5M |
| Total Liabilities | 111k | 473k | 646k | 962k | 1.12M |
| Total Equity | 344k | -352k | -491k | -944k | 1.38M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.27M | -862k | -615k | -148k | -385k |
| Investing | -2k | N/A | N/A | 9k | -948k |
| Financing | N/A | 471k | 623k | 155k | 1.76M |
| Market Cap | 572.1k |
| Price to Earnings Ratio | -0.95 |
| Price to Sales Ratio | 0.57 |
| Price to Cash Ratio | 0.91 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 38.14M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Pascal Biosciences Inc |
| Address |
1900 airport way s, suite 201 seattle, washington 98134 |
| Website | https://www.nevisbrands.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
